A prospective 4-year follow-up study of attention-deficit hyperactivity and relateddisorders. J. Biederman, S. Faraone, S. Milberger, J. Guite, E. Mick, L. Chen, D.
Mennin, A. Marrs, C. Ouellette, P. Moore, T. Spencer, D. Norman, T. Wilens, I. Krausand J. Perrin. Pediatric Psychopharmacology Unit, Massachusetts General Hospital,Boston, USA. JAMA (Journal of the American Medical Association) & Archives. GeneralPsychiatry. Vol. 53 No. 5, May 1996
Evidence of familial association between attention deficit disorder and major affectivedisorders. J. Biederman, S. V. Faraone, K. Keenan and M. T. TsuangPediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
JAMA & Archives. General Psychiatry. Vol. 48 No. 7, July 1991
Attention-Deficit/Hyperactivity Disorder. A Selective Overview. Joseph Biederman.
Biological Psychiatry. Volume 57, Issue 11. Pages 1215-1220 (01 June 2005)
Cortical abnormalities in children and adolescents with attention-deficit hyperactivitydisorder. Sowell Elizabeth R., Thompson Paul M., Welcome Suzanne E.,Henkenius Amy L., Toga Arthur W., Peterson Bradley S. Lancet. 2003, vol. 362,pages. 1699-1707
Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety,and other disorders. J Biederman, J Newcorn and S Sprich. American Journal ofPsychiatry 1991; 148:564-577
Applied Neuropsychology. Special Issue
: Attention Deficit Hyperactivity Disorder (ADHD)and Neuropsychology. Sam Goldstien and Jack Naglieri. Guest Editors. LawrenceErlbaum Associates, Publishers Mahwah, New Jersey. London. Vol 12. No. 2. 2005Issn 0908-4282
Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-Deficit/Hyperactivity Disorder. Joseph Biederman, MD*, John H. Heiligenstein, MD,Douglas E. Faries, PhD, Nora Galil, MD, Ralf Dittmann, MD, PhD||, Graham J. Emslie,MD¶, Christopher J. Kratochvil, MD#, Harry F. Laws, MD and Kory J. Schuh, PhDAtomoxetine ADHD Study Group. PEDIATRICS Vol. 110 No. 6 December 2002, pp.
Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for afamilial subtype? Faraone S.V.1; Biederman J.; Monuteaux M.C. Abstract at:I:\IngentaConnect Attention deficit hyperactivity disorder with bipolar disorder in__.htm
A 55-Year-Old Man With Attention-Deficit/Hyperactivity Disorder. Joseph Biederman,MD, Discussant. JAMA & Archives. Vol. 280 No. 12, September 23, 1998.
Attention-Deficit Hyperactivity Disorder With Bipolar Disorder: A Familial Subtype?.
Faraone, Stephen V. Ph.D.; Biederman, Joseph M.D.; Mennin, Douglas B.A.; Wozniak,Janet M.D.; Spencer, Thomas M.D. Journal of the American Academy of Child &Adolescent Psychiatry. 36(10):1378-1390, October 1997
Validity of DSN-IV Subtypes of Attention-Deficit/Hyperactivity Disorder: A family StudyPerspective. Faraone, Stephen V. Ph.D.; Biederman, Joseph M.D.; Friedman, DeborahB.A. Journal of the American Academy of Child & Adolescent Psychiatry. 39(3):300-
Dopamine, Learning, and Impulsivity: A biological Account of Attention-Deficit/Hyperactivity Disorder. Jonathan Williams, MBBS, MSc, MRCPsychDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, De CrespignyPark, Denmark Hill, London, UK. Peter Dayan, Ph.D. Gatsby ComputationalNeuroscience Unit, University College London, UK. Journal of Child and AdolescentPsychopharmacology. Apr 2005, Vol. 15, No. 2 : 160 -179.
New-Onset Bipolar Disorder in Later Life. Martha Sajatovic, M.D., Frederic C. Blow,Ph.D., Rosalinda V. Ignacio, M.S., and Helen C. Kales, M.D. American Journal ofGeriatric Psychiatry 13:282-289, April 2005
Meta-analysis of family-based association studies between the dopamine transportergene and attention deficit hyperactivity disorder. Purper-Ouakil, D. a; Wohl, M. a b;Mouren, M. C. a c; Verpillat, P. b; Ades, J. b c; Gorwood, P. b c. Psychiatric Genetics.
15(1):53-59, March 2005.
Stimulant Drugs and ADHD Basic and Clinical Neuroscience. Editied by Mary V.
Solanto, May F.T. Sernsten, F. Xavier Castellanos. Oxford University Press 2001.
Attention Genes and ADHD. Edited by Florence Levy and David Hay. Brunner-Routledge. Taylor & Francis Group. 2001.
Clinical Trials. A Practical Approach. Stuart J. Pocock. A Wiley Medical Publication.
John Wiley & Sons. First printed 1983. Reprinted December 1991.
Executive Functions and Attention Deficit Hyperactivity Disorder: Implications of twoconflicting views. Thomas E. Brown. International Journal of Disability, Development andEducation. Vol 53, No 1, March 2006. pp 35 – 46
Value of 99m Tc_TRODAT-1 SPECT to predict clinical response to methylphenidatetreatment in adults with attention deficit hyperactivity disorder. La Fougere C, Krause J,Krause KH, Josef Gildehaus F, Hacker M, Koch W, Hahn K, Tatsch K and Dresel S.
Nuclear Medicine Communications. Vol 27 No 9. pages 733 –737.
Right Parietal Dysfunction in Children with Attention Deficit Hyperctivity DisorderCombined Type: A functional MRI Study. Vance A, Silk TJ, Casey M, Rinehart NH,Bradshaw Jl, Bellgrove MA, Cunnington R. Molecular Psychiatry (advance on linepublication). 1 May 2007 doi:10.1038/sh.np 4001999
Fluoxetine Monotherapy in Attention-Deficit/Hyperactivity Disorder and Comorbid Non-Bipolar Mood Disorders in Children and Adolescents. Humberto Quintana, Grant J.
Butterbaugh, William Purnell and Ann K. Layman. Journal Child Psychiatry and HumanDevelopment Issue Volume 37, Number 3 February, 2007Pages 241-253
Differentiating Bipolar Disorder in Turkish Prepubertal Children with Attention-DeficitHyperactivity Disorder. Rasim Somer Diler, Sukru Uguz, Gulsah Seydaoglu, Nese Erol,Ayse Avci. 2007. Bipolar Disorders. Volume 9 Issue 3 Pages 243 May 2007
Diagnosis and treatment of adults with attention-deficit/hyperactivity disorder.CNSSpectrums. Biederman J, Wilens TE, Spencer TJ, Adler LA. Spectrums. 2007 Apr;12(4Suppl 6):1-15. PMID: 17426673 [PubMed - in process]
A review of driving risks and impairments associated with attention-deficit/hyperactivitydisorder and the effects of stimulant medication on driving performance. Journal ofSafety Research. 2007;38(1):113-28. Epub 2007 Feb 15. Barkley RA, Cox D.
Fatty Acid Metabolism in Neurodevelopmental Disorder: A New Perspective inAssociations Between Attention-deficit Hyperactivity Disorder, Dyslexia, dyspraxia andthe Autistic Spectrum. Richardson, M.A.Ross. Prostaglandins, Leukotrienes andEssential Fatty Acids (200) 63(2) 000-000
The age-dependent decline of attention deficit hyperactivity disorder - a meta-analysis offollow-up studies. Stephan Faraone, Joseph Biederman and Eric Mick. PsychologicalMedicine. 2005. 35, 1 – 7. Cambridge University Press. Doi:10.1017/S003329170500IX.
Is there a relationship between attention deficit hyperactivity disorder and bipolardisorder? Kent L, Craddock N. Department of Psychiatry. University of Brimingham,Queen Elizabeth Psychiatric Hospital. Birmingham. B15 2QZ. U.K. Journal of EffectiveDisorders 2003. Feb:73(3):211-21.
Can adults with attention-deficit/hyperactivity disorder be distinguished from those withcomorbid bipolar disorder? Wilens T.E., Biederman J., Wozniak J., Gunawardens S.,Wong J., Monuteaux M. Clinical Research Program in Pediatric Psychoparmacology,Massachusetts General Hospital. Harvard Medical School. Boston. Biological Psychiatry2003 July 1:54(1):1-8
Current Concepts of the Neurobiology of Attention-Deficit/Hyperactivity Disorder.
Biederman J., Faraone S.V. Pediatric Psychopharmacology Unit of the Child PsychiatryService. Massachusetts General Hospital and Harvard Medical School. USA. Journal ofAttgention Disorders. 2002:6 Suppl 1:S7 – 16.
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. A Randomized, Placebo-Controlled, Dose-ResponseStudy. David Michelson, Douglas Faries, Joachim Wernicke, Douglas Kelsey, KatherineKendrick, F. Randy Salle, Thomas Spencer, and the Atomoxetine ADHD Study Group.
From the Lilly Research Laboratories and Indianan University School of Medicine.
Indianapolis. Indiana University of Cincinnati, Cincinnati, Ohio and MassachusettsGeneral Hospital, Boston Massachusetts. Pediatrics Vol. 108 No. 5 November 2001. pe83
General Bipolar Information The Black Dog Institute. The Black Dog Institute is aneducational, research, clinical and community-oriented facility offering specialistexpertise in mood disorders.
Bipolar World. One of the mission statements: to provide timely information andeducation about Bipolar Disorder - what it is, how it is diagnosed and how it is treated .
Developmental Trajectories of Brain Volume Abnormalities in Children and Adolescentswith Attention-Deficit/Hyperactivity Disorder. F. Xavier Castellanos, MD. Patti R. Lee,MD. Wendy Sharp, MSW. Neal O. Jeffries, PhD. Deanna K. Greenstein, PhD. Liv S.
Clasen. PhD. Jonathan D. Blumenthal, MA. Regina s. James, MD. Christen L. Ebens,BA. James M. Walter, MA. Alex Zijdenbos, PhD. Alan C. Evans, PhD. Jay N. Gledd, MD.
Judith L Rapoport. MD. The Journal of the American Medical Association. Vol 288 No14, October 9, 2002.
McMan's Depression and Bipolar Web. Bipolar Disorder FAQ Part I - III - Overview toBipolar.
The website of R. Kaan Ozbayrak, MD about Asperger’s Disorder:
Tony Attwood’s website. Dr Attwood is a psychologist and is an authority on Asperger’sDisorder in Australia:
The Complete Guide to Asperger’s Syndrome. Tony Attwood. Published by JessicaKingsley. London UK.
Eli Lilly Australia Pty Ltd’s website about Bipolar in Australia:
International Consensus Statement on AD/HD of January 2002:
Dr. Barkley’s talk in San Francisco (2001) – model of AD/HD-C:
Dr. Barkley’s educational material for Health Care Professionals:
Understanding ADHD (Attention Deficit Hyperactivity Disorder). Dr. Christopher Gree
and Dr. Kit Chee. Transworld Publishing a division of Random House PublishingAustralia Pty Ltd. 1994 – 2001.
Asperger’s Syndrome. A guide for Parents and Professionals. Tony Attwood. JessicaKingsley Publishers. London UK. 1998.
The Attention Deficit Answer Book. The Best Medications and Parenting Strategies forYour Child. Alan Wachte, M.D with Michael Boyette. Published by the Penguin Group.
ADHD Recognition Reality and Resolution. Geoffrey Kewley. First published in 1999 byLAC Press (Learing Assessment Centre) West Sussex. This edition published byAustralian Council for Education Research Ltd. Camberwell. Melbourne Victoria.
Quantitative Brain Magnetic Resonance Imaging in Girls with Attention-Deficit/Hyperactivity Disorder. Castellanos F. Xavier, Giedd Jay N, Berquin Patrick C,Walter James M, Sharp Wendy, Tran Thanhian, Vaituzis A Catherine, BlumenthalJonathan D, Nelson Jean, Bastain Theresa M, Zijdenbos Alex, Evans Alan C, RapoportJudith L.
Does Stimulant Therapy of Attention-Deficit/Hyeractivity Disorder Beget Later SubstanceAbuse? A Meta-analytic Review of the Literature. Timothy E Willens MD, Stephen V.
Faraone PhD, Joseph Biederman MD, and Samantha Guawardene BS. Pediatrics Vol111 No. 1 January 2003. pp 179 – 185
The Role of Vascular Risk factors in Late Onset Bipolar Disorder. Hari Subramaniam,Michael S. Dennis and E. Jane Byrne. International Journal of Geriatric Psychiatry.
Published online by Wiley InterScience.
Silent Cerebral Infarctions in Patients With Late-Onset Mania. From the Department ofPsychiatry and Neurosciences, Hiroshima University School of Medicene. (T.F.S.Y) andthe Department of Psychiatry and Neurology, Hiroshima Prefectural Hostipal (Y.T).
New Onset Bipolar Disorder in Later Life. Martha Sajatovic, M.D, Frederic C. Blow PhD,Rosealinda V. Ignacio MS, and Helen C. Kales MD. American Journal of GeriatricPsychiatry.
Early – Versus Late-Onset Bipolar II Disorder. Franco Benassi, MD. Department ofPsychiatry. Morgagni Public Hospital Forli .Italy. Journal of Psychiatry andNeuroscience. Vol 25, No 1. 2000.
The Scientific Foundation for Understanding Attention-Deficit/Hyperactivity Disorder as aValid Psychiatric Disorder. Stephen V. Faraone. Eur Child Adolescent Psychiatry. (2005)14:1-10 DOI 10.1007/s00787-005-0429-z
Electroencephalogram Differences in Two Subtypes of Attention-Deficit/HyperactivityDisorder. Adam R Clarke, Robert J Barry, Rory McCarthy and Mark Selikowitz.
Psychophysiology 38 (2001) 212 – 221. Cambridge University Press. Printed in theUSA.
Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/HyperactivityDisorder. Vincent j. Monastra, Steven Lynn, Michael Linden, Joel F. Lubar, JohnGruzelier and Theodore J La Vague. Applied Psychophysiology and Biofeedback Vol. 30No 2. June 2005.
FEMALE PARTNER MALE PARTNER Surname/Family Name ____________ Surname/Family Name ____________ First Name _____________________ First Name _____________________ Date of Birth ______/__/________ Date of Birth ______/__/________ Nationality ____________________ Nationality ____________________ Religion _______________________ Religion _______________________ Languages Spoken ______
Referral Criteria – Minor Oral Surgery Accepted Rejected Third Molar Removal Accepted for minor oral surgery for teeth meeting NICE guidelines Rejected – Treatment to be undertaken by GDPs Wisdom teeth meeting NICE criteria that are impacted requiring a flap procedure • Impacted wisdom teeth free from disease and bone removal and/or surgical division i.e. wisdom teeth